Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas

BACKGROUND: Chemotherapy for soft tissue sarcomas remains unsatisfactory due to their low chemosensitivity. Even the first line chemotherapeutic agent doxorubicin only yields a response rate of 18-29%. The antibiotic salinomycin, a potassium ionophore, has recently been shown to be a potent compound...

Descripción completa

Detalles Bibliográficos
Autores principales: Liffers, Sven-T, Tilkorn, Daniel J, Stricker, Ingo, Junge, Christoph Günter, Al-Benna, Sammy, Vogt, Markus, Verdoodt, Berlinda, Steinau, Hans-U, Tannapfel, Andrea, Tischoff, Iris, Mirmohammadsadegh, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854645/
https://www.ncbi.nlm.nih.gov/pubmed/24144362
http://dx.doi.org/10.1186/1471-2407-13-490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854645/
https://www.ncbi.nlm.nih.gov/pubmed/24144362
http://dx.doi.org/10.1186/1471-2407-13-490

Ejemplares similares